studi
approv
institut
review
board
nation
jewish
health
denver
co
univers
colorado
denver
denver
co
total
patient
prospect
enrol
studi
tabl
experiment
group
consist
patient
known
cf
document
genotyp
test
nasal
polyposi
visual
nasal
endoscopi
patient
cf
prior
sinu
bronchoalveolar
lavag
cultur
demonstr
colon
staphylococcu
aureu
pseudomona
aeruginosa
comparison
group
consist
patient
without
cf
present
nasal
polyposi
diagnos
histori
physic
examin
nasal
endoscopi
patient
treat
standard
regimen
daili
nasal
steroid
nasal
salin
irrig
prior
biopsi
oral
steroid
use
patient
least
one
month
prior
biopsi
diagnosi
benign
inflammatori
polyp
confirm
hematoxylin
eosin
h
e
stain
biopsi
specimen
obtain
process
follow
manner
patient
biopsi
either
offic
local
anesthesia
onset
definit
surgic
treatment
gener
anesthesia
oper
room
topic
applic
oxymetazolin
lidocain
polypoid
tissu
eman
middl
meatu
grasp
smooth
atraumat
forcep
place
cold
bath
normal
salin
approxim
g
tissu
obtain
patient
specimen
process
accord
guidelin
specifi
sigma
antibodi
microarray
protocol
chemic
reagent
solvent
obtain
sigma
part
antibodi
microarray
kit
cell
signal
approxim
mg
protein
extract
specimen
collect
label
either
dye
accord
standard
procedur
excess
dye
remov
solut
use
sigmaspin
column
equal
amount
protein
specimen
combin
form
group
specimen
grid
array
slide
contain
antibodi
duplic
plu
bovin
serum
albumin
bsa
posit
control
bsa
neg
control
result
total
spot
spot
antibodi
array
previous
valid
abil
bind
protein
array
assay
use
sampl
human
mous
rat
technic
aspect
assay
improv
verifi
variou
mous
incub
array
perform
minut
accord
standard
techniqu
use
provid
buffer
salin
pb
wash
slide
scan
microarray
scanner
raw
intens
valu
record
raw
intens
valu
normal
median
allow
comparison
slide
valu
highli
repeat
revers
well
across
sampl
statist
signific
differenti
regul
protein
establish
analysi
varianc
anova
valid
result
western
blot
analysi
perform
equal
amount
protein
extract
per
lane
biopsi
specimen
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
blot
onto
nitrocellulos
membran
three
addit
cf
patient
enrol
studi
underw
tissu
collect
describ
tissu
harvest
subsequ
protein
microarray
work
therefor
addit
cf
biopsi
specimen
avail
western
blot
analysi
addit
origin
specimen
describ
protein
probe
monoclon
antibodi
visual
use
chemiluminesc
receiv
approv
institut
review
board
univers
colorado
denver
archiv
tissu
block
nasal
polyp
specimen
cf
patient
obtain
univers
colorado
hospit
surgic
patholog
databas
ten
new
new
cf
biopsi
specimen
select
inclus
arm
studi
patient
nasal
polyposi
patient
rang
age
year
patient
record
check
preoper
oral
topic
nasal
steroid
use
tissu
section
mount
charg
glass
slide
superfrost
plu
fisher
scientif
waltham
bake
overnight
monoclon
mous
antibodi
obtain
immunohistochem
stain
dako
carpinteria
ca
slide
deparaffin
xylen
rehydr
grade
alcohol
seri
endogen
peroxidas
activ
block
hydrogen
peroxid
minut
decloak
chamber
biocar
medic
concord
ca
citrat
buffer
mmoll
use
antigen
retriev
minut
autostain
dako
use
perform
stain
envis
dual
link
hrp
dako
detect
kit
use
accord
product
protocol
final
antibodi
dilut
slide
incub
room
temperatur
minut
antibodi
posit
control
slide
section
normal
human
tonsillar
tissu
dako
util
neg
control
stain
perform
section
use
plain
antibodi
diluent
dako
place
antibodi
stain
visual
develop
dako
counterstain
hematoxylin
dehydr
grade
alcohol
coverslip
place
slide
inspect
attend
pathologist
confirm
appropri
stain
slide
digit
origin
magnif
use
scanscop
xt
scanner
aperio
vista
ca
scan
imag
import
imagescop
viewer
posit
pixel
count
algorithm
version
use
calcul
total
tissu
posit
index
specimen
valu
rang
entireti
section
polyp
specimen
includ
analysi
region
artifact
nonspecif
stain
outsid
polyp
exclud
mean
total
tissu
posit
index
experiment
group
calcul
use
mean
well
respect
standard
deviat
cf
group
compar
test
use
statist
analysi
calcul
p
valu
signific
dysregul
discov
cf
group
analysi
data
reveal
upregul
pro
protein
polyp
patient
cf
p
cyclin
heat
shock
protein
tyrosin
hydroxylas
downregul
cf
polyp
group
confirm
find
achiev
immunoblot
western
blot
analysi
suggest
qualit
upregul
analog
cf
tissu
fig
cf
specimen
includ
blot
demonstr
significantli
intens
specimen
mean
total
tissu
posit
indic
group
cf
group
respect
data
confirm
higher
quantit
stain
intens
cf
group
rel
group
p
use
novel
technolog
screen
protein
translat
differ
nasal
polyp
patient
without
cf
use
singl
sigma
antibodi
microarray
express
protein
relat
cell
cytoskeleton
cell
signal
cell
cycl
progress
nuclear
signal
apoptosi
cell
neurobiolog
simultan
investig
array
technolog
use
effect
search
marker
earli
detect
target
therapeut
intervent
breast
cancer
work
repres
protein
profil
nasal
polyp
tissu
although
vast
major
cell
cycl
protein
demonstr
signific
differ
note
signific
upregul
cf
nasal
polyp
tissu
rel
polyp
tissu
confirm
find
use
anoth
novel
technolog
initi
describ
breast
cancer
research
autom
imag
analysi
analysi
allow
rapid
reproduc
quantif
immunohistochem
stain
intens
commonli
studi
analog
immunohistochem
data
suggest
upregul
within
cf
nasal
polyp
tissu
rel
polyp
tissu
prior
studi
demonstr
increas
epitheli
cell
prolifer
nasal
polyp
evidenc
higher
proport
polyp
epitheli
cell
mitosi
addit
studi
shown
even
higher
proport
cell
cf
polyp
subtyp
initi
belief
molecular
differ
nasal
polyp
cf
bcl
famili
protein
regul
apoptosi
pathway
known
interact
multitud
cell
regulatori
protein
includ
map
cyclin
sever
kinas
protein
role
progress
consid
domin
regul
apoptosi
known
regul
product
macrophag
found
higher
amount
granulocyt
patient
cf
rat
model
interact
coronaviru
prevent
apoptosi
epitheli
cell
caus
acut
infect
becom
furthermor
bcl
famili
protein
close
tie
dysregul
recent
associ
increas
lymphocyt
infiltr
nasal
upregul
protein
may
interfer
normal
clearanc
cell
tissu
homeostasi
cf
patient
thu
contribut
refractori
sinonas
diseas
polyp
group
number
limit
exist
use
protein
microarray
first
array
protocol
possibl
separ
individu
contribut
epitheli
fibroblast
lymphocyt
popul
within
overal
protein
extract
result
technolog
conclud
cell
type
dysregul
second
patholog
differ
may
innat
diseas
process
may
effect
local
microenviron
polyp
biopsi
perhap
chronic
inflamm
result
aureu
p
aeruginosa
contribut
chang
protein
express
third
patient
patient
variabl
may
becom
factor
group
sampl
togeth
instanc
singl
patient
highli
express
particular
protein
protein
may
appear
dysregul
overal
group
last
one
must
consid
result
demonstr
roughli
dysregul
anecdot
experi
even
higher
dysregul
may
discov
use
array
henc
somewhat
arbitrari
level
one
consid
suggest
function
signific
dysregul
base
array
result
interpret
immunohistochem
stain
autom
imag
analysi
protocol
emerg
technolog
analysi
carri
multipl
limit
well
first
mani
program
design
quantifi
intens
stain
specif
chromogen
algorithm
use
studi
differenti
specif
nonspecif
background
stain
attempt
overcom
limit
review
slide
attend
pathologist
ensur
stain
specif
insignific
degre
nonspecif
background
stain
present
second
train
pathologist
superior
comput
program
distinguish
specif
cell
type
determin
popul
might
associ
higher
intens
stain
algorithm
distinguish
cell
type
rather
quantifi
averag
stain
intens
entir
polyp
last
chromogen
diaminobenzidin
demonstr
linear
relationship
antigen
concentr
stain
intens
certain
antigen
concentr
consequ
potenti
nonlinear
relationship
antigen
concentr
stain
intens
may
potenti
result
inaccur
result
output
autom
imag
analysi
program
studi
demonstr
increas
express
famili
protein
nasal
polyp
tissu
harvest
patient
cf
three
techniqu
studi
protein
express
use
protein
microarray
western
immunoblot
immunohistochem
stain
protein
microarray
may
use
tool
mass
analysi
chang
protein
express
cultur
cell
fresh
tissu
techniqu
rapid
easi
use
detect
protein
level
low
nanogram
per
millilit
autom
imag
analysi
immunohistochem
stain
anoth
rapid
techniqu
reduc
arbitrari
natur
tradit
score
system
use
emerg
technolog
studi
cf
nasal
polyp
suggest
upregul
famili
protein
tissu
rel
nasal
polyp
dysregul
cell
cycl
apoptot
pathway
may
contributori
role
pathophysiolog
polyp
format
progress
patient
cf
studi
necessari
confirm
appli
find
